Trial intelligence / Profile preview

Ultrasound-guided Foam Sclerotherapy for Varicose Veins

NCT04655417Phase 1Unknown

Sponsor
Combined Military Hospital
Start
Feb 2020
Primary completion
Feb 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of sodium tetradecyl sulfate in Varicose Veins, sponsored by Combined Military Hospital. Primary endpoints: pain by VAS score at 1 month, leg edema at 1 month and 2 more. Status: unknown.

02

Drugs

sodium tetradecyl sulfate
03

Conditions

Varicose Veins

Beyond the preview

Go deeper on NCT04655417.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04655417.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call